Univfy
About Univfy
The Univfy AI Platform helps women and couples navigate their family-building options with cost-savings, greater success, and a simplified experience. Univfy combines AI/machine learning, clinical expertise, and empathy to maximize each patient’s chances of success with assisted reproductive technology such as in vitro fertilization (IVF) while increasing growth and efficiency for physicians. Univfy is the only highly-scalable AI platform to provide scientifically-validated, personalized reports that counsel patients from diverse demographics about their probability of having a baby with IVF. Through technology developed by Stanford University researchers, Univfy uses a rigorous scientific process to develop and validate prediction models and to provide essential information to support better budgeting, planning, and physician-patient shared decision-making. Its methods have been published in the top, peer-reviewed research publications, setting a gold standard for IVF success model performance metrics. Univfy has a global IP portfolio, comprising patents issued in the US and other countries.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 15 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 12700000 USD
- Last Funding: 6000000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Univfy actively uses 15 products in their tech stack.
Market Presence
Industries: Artificial Intelligence, Health Care, Life Science, Machine Learning, PaaS, Personal Health, Predictive Analytics
Headquarters: Los Altos, California, United States
Leadership
- Mylene Yao - Co-founder, Director, CEO LinkedIn